Celularity Begin Period Cash Flow from 2010 to 2024
| CELU Stock | USD 2.76 0.09 3.16% |
Begin Period Cash Flow | First Reported 2019-03-31 | Previous Quarter 15.1 M | Current Value 11.9 M | Quarterly Volatility 30.4 M |
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
Celularity | Begin Period Cash Flow |
Latest Celularity's Begin Period Cash Flow Growth Pattern
Below is the plot of the Begin Period Cash Flow of Celularity over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. Celularity's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
| Begin Period Cash Flow | 10 Years Trend |
|
Begin Period Cash Flow |
| Timeline |
Celularity Begin Period Cash Flow Regression Statistics
| Arithmetic Mean | 15,787,204 | |
| Geometric Mean | 302,688 | |
| Coefficient Of Variation | 154.68 | |
| Mean Deviation | 21,016,663 | |
| Median | 24,707 | |
| Standard Deviation | 24,418,935 | |
| Sample Variance | 596.3T | |
| Range | 69.5M | |
| R-Value | 0.75 | |
| Mean Square Error | 285.3T | |
| R-Squared | 0.56 | |
| Significance | 0 | |
| Slope | 4,070,672 | |
| Total Sum of Squares | 8348T |
Celularity Begin Period Cash Flow History
About Celularity Financial Statements
Celularity shareholders use historical fundamental indicators, such as Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Begin Period Cash Flow | 28.8 M | 42.7 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Celularity Stock Analysis
When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.